Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
Conditions: Latent Tuberculosis; Diabetes Mellitus, Type 2 Interventions: Drug: Rifampicin 300 Mg Oral Capsule; Drug: Isoniazid 300 MG Sponsor: Herlev and Gentofte Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials